Folger Nolan Fleming Douglas Capital Management’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7M Sell
81,539
-916
-1% -$284K 2.18% 10
2026
Q1
$24.3M Buy
82,455
+2,957
+4% +$897K 2.17% 11
2025
Q4
$25.6M Sell
79,498
-173
-0.2% -$53.6K 2.63% 8
2025
Q3
$25.1M Sell
79,671
-1,196
-1% -$356K 2.62% 7
2025
Q2
$23.4M Sell
80,867
-1,813
-2% -$463K 2.6% 7
2025
Q1
$20.3M Sell
82,680
-1,546
-2% -$394K 2.29% 7
2024
Q4
$20.2M Sell
84,226
-5,231
-6% -$1.22M 2.12% 9
2024
Q3
$18.9M Sell
89,457
-4,293
-5% -$904K 1.86% 11
2024
Q2
$19M Sell
93,750
-81
-0.1% -$15.8K 1.94% 10
2024
Q1
$18.8M Sell
93,831
-186
-0.2% -$33.6K 1.92% 11
2023
Q4
$16M Sell
94,017
-899
-0.9% -$136K 1.74% 15
2023
Q3
$13.8M Sell
94,916
-2,829
-3% -$424K 1.6% 17
2023
Q2
$14.2M Buy
97,745
+653
+0.7% +$89.8K 1.55% 17
2023
Q1
$12.7M Sell
97,092
-1,461
-1% -$200K 1.48% 18
2022
Q4
$13.3M Buy
98,553
+2,225
+2% +$282K 1.6% 14
2022
Q3
$10.1M Buy
96,328
+914
+1% +$105K 1.37% 20
2022
Q2
$10.7M Buy
95,414
+931
+1% +$115K 1.41% 21
2022
Q1
$12.9M Buy
94,483
+1,263
+1% +$186K 1.44% 18
2021
Q4
$14.8M Sell
93,220
-856
-0.9% -$141K 1.61% 18
2021
Q3
$15.4M Buy
94,076
+378
+0.4% +$59.3K 1.85% 14
2021
Q2
$14.6M Buy
93,698
+1,009
+1% +$158K 1.69% 15
2021
Q1
$14.1M Buy
92,689
+792
+0.9% +$114K 1.71% 13
2020
Q4
$11.7M Sell
91,897
-760
-0.8% -$84.9K 1.54% 18
2020
Q3
$8.92M Buy
92,657
+580
+0.6% +$57K 1.34% 21
2020
Q2
$8.66M Sell
92,077
-385
-0.4% -$36.5K 1.41% 20
2020
Q1
$8.32M Sell
92,462
-1,987
-2% -$241K 1.66% 18
2019
Q4
$13.2M Sell
94,449
-930
-1% -$119K 1.92% 8
2019
Q3
$11.2M Buy
95,379
+1,517
+2% +$172K 1.73% 13
2019
Q2
$10.5M Buy
93,862
+230
+0.2% +$25.4K 1.57% 17
2019
Q1
$9.48M Buy
93,632
+1,339
+1% +$138K 1.42% 16
2018
Q4
$9.01M Buy
92,293
+836
+0.9% +$89.1K 1.48% 15
2018
Q3
$10.3M Buy
91,457
+1,542
+2% +$175K 1.46% 13
2018
Q2
$9.37M Buy
89,915
+2,331
+3% +$256K 1.36% 13
2018
Q1
$9.63M Sell
87,584
-915
-1% -$104K 1.43% 12
2017
Q4
$9.46M Sell
88,499
-3,855
-4% -$390K 1.32% 13
2017
Q3
$8.82M Buy
92,354
+518
+0.6% +$47.8K 1.28% 14
2017
Q2
$8.39M Buy
91,836
+13
+0% +$1.12K 1.29% 14
2017
Q1
$8.07M Buy
91,823
+733
+0.8% +$64.7K 1.2% 15
2016
Q4
$5.83M Hold
91,090
0.96% 21
2016
Q3
$5.83M Sell
91,090
-25
-0% -$1.63K 0.96% 21
2016
Q2
$5.66M Buy
91,115
+1,330
+1% +$83.1K 0.97% 21
2016
Q1
$5.32M Buy
89,785
+3,030
+3% +$177K 0.95% 22
2015
Q4
$5.73M Buy
86,755
+1,107
+1% +$72.1K 1.02% 20
2015
Q3
$5.22M Buy
85,648
+1,700
+2% +$111K 1.07% 20
2015
Q2
$5.69M Sell
83,948
-161
-0.2% -$10.5K 1.05% 18
2015
Q1
$5.09M Buy
84,109
+829
+1% +$49.1K 0.89% 21
2014
Q4
$5.21M Buy
83,280
+1,890
+2% +$114K 0.89% 22
2014
Q3
$4.9M Buy
81,390
+2,890
+4% +$169K 0.88% 21
2014
Q2
$4.52M Buy
78,500
+5,327
+7% +$299K 0.83% 23
2014
Q1
$4.44M Sell
73,173
-2,905
-4% -$168K 0.91% 23
2013
Q4
$4.45M Buy
76,078
+1,637
+2% +$89.7K 0.78% 23
2013
Q3
$3.85M Buy
74,441
+5,765
+8% +$309K 0.74% 26
2013
Q2
$3.63M Buy
+68,676
New +$3.49M 0.75% 25

Other funds holding JPM

Folger Nolan Fleming Douglas Capital Management's JPM Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its JPMorgan Chase (JPM) stake by 1.1% in Q2 2026, selling an estimated $284K and leaving 81,539 shares worth $26.7M. The position accounts for 2.18% of the portfolio, ranked #10.

Folger Nolan Fleming Douglas Capital Management first reported a position in JPM in Q2 2013 and has held it in 53 quarters since. 1,839 funds tracked by Wall St. Rank hold JPM as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 81,539 shares of JPMorgan Chase worth $26.7M as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 916 JPMorgan Chase shares in Q2 2026, an estimated $284K.
  • JPMorgan Chase made up 2.18% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #10 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in JPMorgan Chase in Q2 2013 and has held it in 53 quarters since.
  • 1,839 funds tracked by Wall St. Rank held JPMorgan Chase as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.